Performance of the HAS‐BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database
Background The association between cancer types and specific bleeding events in patients with atrial fibrillation has been scarcely investigated. Also, the performance of bleeding risk scores in this high‐risk subgroup of patients is unclear. We investigated the rate of any bleeding, intracranial he...
Main Authors: | Daniele Pastori, Amélie Marang, Arnaud Bisson, Julien Herbert, Gregory Yoke Hong Lip, Laurent Fauchier |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.026388 |
Similar Items
-
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
by: Joshua D. Brown, et al.
Published: (2018-03-01) -
HAS-BLED vs. ORBIT scores in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis
by: Xuyang Liu, et al.
Published: (2023-01-01) -
Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Xinxing Gao, et al.
Published: (2021-11-01) -
Empiric Anticoagulation Therapy in Hospitalized COVID-19 Patients: An Evaluation of Bleeding Risk Scores Performances in Predicting Bleeding Events
by: Mona A. Abdelrahman, et al.
Published: (2022-08-01) -
Revised HAS‐BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
by: Komsing Methavigul
Published: (2022-06-01)